www.dys.com
  English Français
 
 


Sandoz*, specialist manufacturer of generic medicinal products, manages its Supply Chain with n.SKEP® from DynaSys

 
   
  News & events
  Events
  Press Room
    2004-2005
    2006 - 2008
 
 
  Back

 

January, the 11 th 2005

Subsidiary of the German Hexal group (4th largest specialist manufacturer of generic medicinal products world-wide) and founded in 1999, G.Gam is currently the 2nd laboratory of generic medicaments in Europe . Located in France , the turnover of G.Gam in 2003 reached 50 million euros, - amongst which 94% in France (by hospitals, wholesalers, and dispensaries) and 6% abroad (North and black Africa , as well as French overseas departments and territories) -, with a yearly growth from 50% up to 100%. Offering 200 items, the G.Gam company employs 100 people and its organization is mainly based on sales; fifty medical representatives daily deal with chemists and through distribution networks. The company also manages 25 subcontractors.

 

Faced with a growing demand for generic medicinal products (fifty new molecules are planed to be marketed by G.Gam in 2005), and with a continuously growing market, G.Gam was fast confronted with different challenges: launching of3 or 4 generic products a month, apart from the numerous items to be managed daily; gather all the sales, finance and productionfunctions to enable more flexibility and receptiveness as well as more productivity; better control financial profitability, by a significant decrease of stocks.

 

As a result, in June 2004 the G.Gam Laboratories began looking for an APS system, which would enable them to integrate the demand management and forecasting functions, as well as the procurement planning functions.

 

After a quick market review (4 main Supply Chain providers were consulted), G.Gam decided, in November 2004, to select the DynaSys’ solution n.SKEP Demand Planning (for the calculation and reliability of logistic forecasts) and n.SKEP Procurement Planning (to generate the procurement requirements).

 

‘We wanted to work closely with a software author able to understand very quickly our specific business challenges. Moreover, we needed an intelligent system,able to integrate and to communicate with our existing business systems, and particularly our pharmaceutical databases’, comments Cyrille Sidawy, Head of Industrial Operations at G.Gam.

 

‘DynaSys has exactly met all these criteria. We also appreciated the professionalism and the flexibility of the DynaSys pre-sales team, who managed to adapt very quickly to our methods of working, adds Cyrille Sidawy. Thanks to the DynaSys solutions, we hope to reduce our stocks of about 20-30%, to improve significantly our sales forecasts, to diminish our transportation costs and to improve our ability to address customer demands and improve supply performance. We also plan to acquire next year a collaborative Web solution that will enable us to have real time communication with our manufacturers (more efficient management of subcontracting)’.

 

Ariel Weil, General Manager Assistant of DynaSys, goes on: ‘We had a clear objective: enable the G.Gam Laboratories to be operative in less than six months and to enable them to significantly improve response times, whilst reacting to changes to external constraints. Thanks to our proven business approach and to our flexible and powerful solutions, we can offer to all our customers a solution that addresses their challenges within very short lead times.’

 

* On January the 26th 2006, the G.Gam Laboratory and the Sandoz Laboratory have merged. The G.Gam company has been disolved. A new entity has been created: the Sandoz Laboratory.


Top